Health care facilities accommodation of cannabis and hemp products requirement provision

Minnesota Senate Bill 3349, introduced by Senator Doron Clark on April 9, 2025, requires health care facilities to accommodate patients' use of medical cannabis and hemp products. The bill amends Minnesota Statutes 2024, section 342.56, subdivision 2, to mandate that licensed health care facilities, including hospitals, assisted living facilities, and boarding care homes, must allow patients to use medical cannabis flower, medical cannabinoid products, lower-potency hemp edibles, hemp-derived consumer products, and hemp-derived topical products. The facilities may adopt reasonable restrictions on the use of these products but cannot prohibit their use outright. The bill was referred to the Senate Commerce and Consumer Protection Committee on the same day it was introduced. ([legiscan.com](https://legiscan.com/MN/bill/SF3349/2025?utm_source=openai))

While there is no direct media coverage of Senate Bill 3349, the bill aligns with ongoing efforts in Minnesota to expand access to cannabis and hemp products. For instance, in February 2026, an administrative law judge ruled that retailers could ship hemp-derived products directly to customers, overturning a previous in-person sales requirement. ([startribune.com](https://www.startribune.com/judge-tosses-minnesota-ban-on-shipping-hemp-products/601581151?utm_source=openai)) This ruling indicates a trend toward greater acceptance and accommodation of hemp products in the state. Additionally, in September 2022, a Minnesota medical marijuana company sued the state to sell its edibles on the open market, arguing that its products are chemically identical to THC edibles derived from legal hemp. ([startribune.com](https://www.startribune.com/minnesota-medical-marijuana-company-sues-state-seeks-to-sell-some-of-its-edibles-on-open-market/600208397/?utm_source=openai)) These developments suggest a growing recognition of the need for health care facilities to accommodate cannabis and hemp products.

There is no direct media coverage of Senate Bill 3349. However, the bill's introduction may face challenges due to the complex regulatory environment surrounding cannabis and hemp products in Minnesota. For example, in September 2022, a Minnesota medical marijuana company sued the state to sell its edibles on the open market, highlighting ongoing legal disputes over the commercialization of cannabis products. ([startribune.com](https://www.startribune.com/minnesota-medical-marijuana-company-sues-state-seeks-to-sell-some-of-its-edibles-on-open-market/600208397/?utm_source=openai)) Additionally, in February 2026, an administrative law judge overturned a state ban on shipping hemp products, indicating that regulatory changes are subject to legal scrutiny and may face opposition. ([startribune.com](https://www.startribune.com/judge-tosses-minnesota-ban-on-shipping-hemp-products/601581151?utm_source=openai)) These instances suggest that the bill may encounter resistance from stakeholders concerned about the implications of accommodating cannabis and hemp products in health care settings.